Shareholdings
| Concept |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2025-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
As at 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholdings | ||||||||||||||||
| Reporting company | ||||||||||||||||
| Details of specified investment shares held for purposes other than pure investment | ||||||||||||||||
| Issue |
久光製薬㈱
|
あすか製薬ホールディングス㈱
|
サワイグループホールディングス㈱
|
大塚ホールディングス㈱
|
㈱ケイファーマ
|
㈱ファルコホールディングス
|
㈱イーエムシステムズ
|
メディアスホールディングス㈱
|
— | — | — | — | — | — | — | — |
| Number of shares |
67,000
xbrli:shares
|
xbrli:shares
|
165,000
xbrli:shares
|
800,000
xbrli:shares
|
315,700
xbrli:shares
|
105,300
xbrli:shares
|
600,000
xbrli:shares
|
382,800
xbrli:shares
|
315,700
xbrli:shares
|
382,800
xbrli:shares
|
800,000
xbrli:shares
|
600,000
xbrli:shares
|
105,300
xbrli:shares
|
150,000
xbrli:shares
|
67,000
xbrli:shares
|
55,000
xbrli:shares
|
| Carrying amount |
271,000,000
JPY
|
JPY
|
326,000,000
JPY
|
6,202,000,000
JPY
|
257,000,000
JPY
|
244,000,000
JPY
|
475,000,000
JPY
|
362,000,000
JPY
|
192,000,000
JPY
|
298,000,000
JPY
|
5,048,000,000
JPY
|
425,000,000
JPY
|
246,000,000
JPY
|
332,000,000
JPY
|
266,000,000
JPY
|
331,000,000
JPY
|
| Purpose of shareholding, overview of business alliance, quantitative effects of shareholding and reason for increase in number of shares |
・良好な取引関係の維持発展・当社グループの取引先・検証実施(注)１
|
・良好な取引関係の維持発展・当社グループの取引先・検証実施(注)１
|
・良好な取引関係の維持発展・当社グループの取引先・検証実施(注)１・株式分割
|
・良好な取引関係の維持発展・当社グループの取引先・検証実施(注)１
|
・良好な取引関係の維持発展・当社グループの取引先・検証実施(注)１
|
・良好な取引関係の維持発展・当社グループの取引先・検証実施(注)１
|
・良好な取引関係の維持発展・当社グループの取引先・検証実施(注)１
|
・良好な取引関係の維持発展・当社グループの取引先・検証実施(注)１
|
— | — | — | — | — | — | — | — |
| Whether issuer of aforementioned shares holds reporting company's shares |
有
|
無
|
無(注)３
|
無(注)３
|
無
|
無
|
無
|
無
|
— | — | — | — | — | — | — | — |